Patients and methods Hpylori eradication in subjects with a history of at least two symptomatic recurrences and an endoscopically confirmed, active duodenal ulcer was achieved with a 12 day regimen of amoxicillin (750 mg three times daily) plus metronidazole (500 mg three times daily), already described elsewhere.5 Additional ranitidine was given for six (or 10) weeks. After ulcer healing and H pylori eradication, control endoscopies were performed on months 4, 8, 14±1, 27±2, and 43±4 after starting treatment or whenever symptoms occurred. If reinfection was detected, the spouse of the reinfected patient was also asked to undergo endoscopy.
ient K before onset of treatment; 8=patient K at month 43 pten wh had not been reinetd n l spouse ofpatient K patients who had not been reinfected, no ulcer relapses could be seen and they continued to be free of related symptoms. In one of performed using polymerase chain reaction these patients reflux oesophagitis was diag-(PCR) based DNA fingerprinting. Arbitrary nosed at the control after 14 months. After primer (AP) PCR was used to detect any DNA 27 months of follow up, three of the patients sequence diversity among the Hpylori isolates. had developed reflux oesophagitis, a finding The H pylori DNA was prepared by repeated which was deemed without particular signififreezing and thawing of a suspension of cance by the investigators. At the end of the H pylori in phosphate buffered saline. follow up period, however, reflux oesophagitis Phenol/chloroform extraction, precipitation of (Savary-Miller grade 1) was seen in 10 of those DNA and PCR were performed as described who had not been reinfected. Most of them by Akopyanz et al.6 For PCR a lOnt-primer had not spontaneously complained about their 5'-CCGCAGCCAA-3' was used. reflux symptoms because they had not associated the mild heartburn experienced with their ulcer disease. Results Eighteen patients (14 men and four women with a mean age of 50 years) with healed duodenal ulcers and eradicated H pylori were entered into the follow up study. SEROLOGY Figure, the H pylon strains found in patient L before the onset of Discussion Since H pylori shows a high degree of genomic diversity most patients carry an individual strain with a unique pattern.7 As shown by Bamford et al, different family members may be infected with the same strain, but usually typable strains differ significantly from patient to patient.6 8 9 For cases where strains with an identical DNA pattern can be detected before eradication and after H pylori reinfection, two principal explanations may be suggested as follows:
(i) A relapse -that is the organism was not completely eradicated, but only transiently suppressed. This is highly unlikely in our two cases, because H pylori was only redetected at 14 and 43 months respectively after the onset of treatment.
(ii) Reinfection with the same strain; this would be possible by transmission from family members or spouses infected with the identical strain.
The data available on the person to person spread of these bacterial organisms are rather inconsistent. Malaty et al report a high incidence of H pylori infections in spouses of H pylori positive patients and intrafamilial clustering of H pylori infections has been described by Drumm et al.'0 1 In obvious contrast, Perez-Perez et al suggest that person to person transmission does not occur at all, or at least only infrequently.12 The results of all these studies are exclusively based on serological data and did not involve any DNA analyses. In our investigations, no genomic diversity could be seen for the isolates of the spouses and those of the reinfected patients. With the identification of identical strains in both the healthy H pylori carrying spouse and the reinfected patient, conjugal transmission in reinfection has been shown for the first time with near certainty. A common exogenous source of H pylori cannot be ruled out altogether, but seems rather unlikely.
Reinfection rates have generally been reported to range between 0O48 and 35.3% in one year.3 13 While the reinfection rates described for investigations based on noninvasive methods are similarly low as those for seroconversion studies, endoscopic follow up usually shows higher rates.3 1419 In our study, a reinfection rate of 3-1% per patient year was seen, with excellent correlation between serological evidence of reinfection and its demonstration by microbiological and histopathological methods.
To our knowledge, the development of reflux oesophagitis after H pylori eradication has never been reported. We do not believe that this was an accidental finding or that reflux oesophagitis escaped the attention of the experienced endoscopists at the preceding gastroscopies. We think that its development was caused by the changed eating and drinking habits of patients after the healing of their duodenal ulcer disease. The patients were no longer bound to any dietary regimen and all of them showed an obvious weight gain. Upon inquiry, they reported having been able to enjoy acid producing foods and those that reduced lower oesophageal sphincter pressure and alcoholic beverages after Hpylori eradication.
In conclusion, these results provide evidence that reinfection with Hpylori may be caused by the same H pylori strain. Serological follow up seems to be sufficient for the detection of reinfection. Person to person transmission is the most likely mechanism and this warrants looking for H pylorn IgG antibodies in the spouse of a duodenal ulcer patient reinfected with this organism. In the case of positive results anti-H pylori treatment of both patient and spouse is well worth considering.
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